CLEC3B and hepatocellular carcinoma: Dai and his team found that the downregulation of exosomes CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis through AMPK and VEGF signaling and is a potential therapeutic target for hepatocellular carcinoma (43).